NUTX To Focus On Core Drug Delivery and Probiotic Businesses
REDMOND, Wash.–(BW HealthWire)–Nutraceutix Inc. (OTC BB: NUTX – news), has sold its production rights for Micro-Cell® direct-fed animal health products to Lallemand Animal Nutrition, North America, a subsidiary of Lallemand Inc.
Under terms of the agreement, Nutraceutix has sold its rights to produce Micro-Cell® microbial beef feed additive. Nutraceutix retains the intellectual property rights and production of its Cobactin® microbial feed additive product, while Lallemand Animal Nutrition will have the exclusive rights to distribute the product. Additional terms of the agreement were not disclosed.
According to David Howard, president & chief executive officer of Nutraceutix Inc., “This agreement allows Nutraceutix to focus on its core business strategy, which has changed considerably with new intellectual property in both our drug delivery and probiotic businesses.
“We are now better able to concentrate on business opportunities aligned with our core competencies and growing intellectual property position.”
Based in Redmond, Nutraceutix Inc. is a biopharmaceutical company leveraging specialized knowledge, proprietary and patented products and technologies such as LiveBac® Probiotics and patented CDT(TM) Controlled Delivery Technology platform.
Nutraceutix technologies provide distinctive products with tangible benefits for the consumer and competitive commercial advantages. Established partnerships with pharmaceutical and natural products industry companies enable Nutraceutix to co-develop new products and to add value and protection to existing product franchises.
For more information on Nutraceutix, please call 800/548-3222 or visit www.nutraceutix.com/.
